BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38431385)

  • 1. The immunogenicity of p24 protein from HIV-1 virus is strongly supported and modulated by coupling with liposomes and mannan.
    Zachová K; Bartheldyová E; Hubatka F; Křupka M; Odehnalová N; Turánek Knötigová P; Vaškovicová N; Sloupenská K; Hromádka R; Paulovičová E; Effenberg R; Ledvina M; Raška M; Turánek J
    Carbohydr Polym; 2024 May; 332():121844. PubMed ID: 38431385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Oxy lipid-based click chemistry for orthogonal coupling of mannan onto nanoliposomes prepared by microfluidic mixing: Synthesis of lipids, characterisation of mannan-coated nanoliposomes and in vitro stimulation of dendritic cells.
    Bartheldyová E; Turánek Knotigová P; Zachová K; Mašek J; Kulich P; Effenberg R; Zyka D; Hubatka F; Kotouček J; Čelechovská H; Héžová R; Tomečková A; Mašková E; Fojtíková M; Macaulay S; Bystrický P; Paulovičová L; Paulovičová E; Drož L; Ledvina M; Raška M; Turánek J
    Carbohydr Polym; 2019 Mar; 207():521-532. PubMed ID: 30600036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine.
    Sadat Larijani M; Ramezani A; Mashhadi Abolghasem Shirazi M; Bolhassani A; Pouriayevali MH; Shahbazi S; Sadat SM
    Virus Res; 2021 Jun; 298():198403. PubMed ID: 33775753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination.
    Aline F; Brand D; Pierre J; Roingeard P; Séverine M; Verrier B; Dimier-Poisson I
    Vaccine; 2009 Aug; 27(38):5284-91. PubMed ID: 19450633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
    Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin-minimized HIV-1 p24 fused to murine hsp70 activates dendritic cells, facilitates endocytosis and p24-specific Th1 response in mice.
    Krupka M; Zachova K; Cahlikova R; Vrbkova J; Novak Z; Sebela M; Weigl E; Raska M
    Immunol Lett; 2015 Jul; 166(1):36-44. PubMed ID: 26021827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines.
    Qiao C; Liu J; Yang J; Li Y; Weng J; Shao Y; Zhang X
    Biomaterials; 2016 Apr; 85():1-17. PubMed ID: 26851653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.
    Kim BJ; Kim BR; Kook YH; Kim BJ
    Front Immunol; 2018; 9():643. PubMed ID: 29636755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells.
    White KL; Rades T; Furneaux RH; Tyler PC; Hook S
    J Pharm Pharmacol; 2006 Jun; 58(6):729-37. PubMed ID: 16734974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.
    Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L
    J Virol; 2021 May; 95(12):. PubMed ID: 33789991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
    Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
    J Virol; 2017 May; 91(9):. PubMed ID: 28202751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
    Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
    Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes.
    Chang JS; Choi MJ; Kim TY; Cho SY; Cheong HS
    Vaccine; 1999 Mar; 17(11-12):1540-8. PubMed ID: 10195791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4
    Ngu LN; Nji NN; Ambada GE; Sagnia B; Sake CN; Tchadji JC; Njambe Priso GD; Lissom A; Tchouangueu TF; Manga Tebit D; Waffo AB; Park CG; Steinman RM; Überla K; Nchinda GW
    Immun Inflamm Dis; 2019 Jun; 7(2):55-67. PubMed ID: 28474788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody.
    Toda S; Ishii N; Okada E; Kusakabe KI; Arai H; Hamajima K; Gorai I; Nishioka K; Okuda K
    Immunology; 1997 Sep; 92(1):111-7. PubMed ID: 9370932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes.
    Abdel-Motal UM; Wang S; Awad A; Lu S; Wigglesworth K; Galili U
    Vaccine; 2010 Feb; 28(7):1758-65. PubMed ID: 20034607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein.
    Bui T; Dykers T; Hu SL; Faltynek CR; Ho RJ
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):799-806. PubMed ID: 8021814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.
    Steers NJ; Peachman KK; McClain SR; Alving CR; Rao M
    J Virol; 2009 Jul; 83(14):7049-61. PubMed ID: 19403671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.